The biggest proposed deal in drug industry history is dead. Or, dead for now.
Pfizer, the largest US drugmaker, yesterday abandoned its effort to buy AstraZeneca for £69.4 billion, saying the public bid rejected by its London-based competitor represented “full value.” AstraZeneca said it welcomed “the opportunity to continue building on the momentum we have already demonstrated.”
Under British takeover rules, Pfizer had until 5pm London time yesterday to make a...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team